A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Authors
Keywords
-
Journal
EXPERIMENTAL DERMATOLOGY
Volume 27, Issue 6, Pages 611-624
Publisher
Wiley
Online
2018-03-31
DOI
10.1111/exd.13548
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects
- (2018) Ulrich Mrowietz et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- The role of IL-4 in psoriasis
- (2017) Matthias Hahn et al. Expert Review of Clinical Immunology
- Exome-wide association study reveals novel psoriasis susceptibility locus at TNFSF15 and rare protective alleles in genes contributing to type I IFN signalling
- (2017) Nick Dand et al. HUMAN MOLECULAR GENETICS
- Differential induction of ATF3 and HO-1 in myeloid cells and keratinocytes via Dimethylfumarate or Cyclosporine A
- (2017) Stefanie Müller et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients
- (2017) Qi Wu et al. JOURNAL OF IMMUNOLOGY
- Anti-Psoriatic Drug Monomethylfumarate Increases Nuclear Factor Erythroid 2-Related Factor 2 Levels and Induces Aquaporin-3 mRNA and Protein Expression
- (2017) Inas Helwa et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Progressive multifocal leukoencephalopathy associated with fumaric acid esters treatment in psoriasis patients
- (2017) D.M.W. Balak et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Cytosolic RNA:DNA Duplexes Generated by Endogenous Reverse Transcriptase Activity as Autonomous Inducers of Skin Inflammation in Psoriasis
- (2017) Jean-Pierre Molès et al. PLoS One
- Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation
- (2017) Jürgen Brück et al. Scientific Reports
- Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms
- (2016) Melanie S. Brennan et al. ANTIOXIDANTS & REDOX SIGNALING
- Dimethyl fumarate activates the prostaglandin EP2 receptor and stimulates cAMP signaling in human peripheral blood mononuclear cells
- (2016) Sarah E. Fiedler et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB
- (2016) Jan P. Nicolay et al. BLOOD
- Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm® - and placebo-controlled trial (BRIDGE)
- (2016) U. Mrowietz et al. BRITISH JOURNAL OF DERMATOLOGY
- Dimethyl- and monomethylfumarate regulate indoleamine 2,3-dioxygenase (IDO) activity in human immune cells
- (2016) Sevgi Eminel et al. EXPERIMENTAL DERMATOLOGY
- Fumaric acid esters for psoriasis: a systematic review
- (2016) D. Smith IRISH JOURNAL OF MEDICAL SCIENCE
- Dimethylfumarate Impairs Neutrophil Functions
- (2016) Susen Müller et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation
- (2016) Victoria A. McGuire et al. Scientific Reports
- The role of transcription factor Nrf2 in skin cells metabolism
- (2015) Agnieszka Gęgotek et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Dimethyl fumarate induces necroptosis in colon cancer cells through GSH depletion/ROS increase/MAPKs activation pathway
- (2015) Xin Xie et al. BRITISH JOURNAL OF PHARMACOLOGY
- The effect of dimethyl fumarate on gene expression and the level of cytokines related to different T helper cell subsets in peripheral blood mononuclear cells of patients with psoriasis
- (2015) Sahar Tahvili et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Fumaric Acid Esters Do Not Reduce Inflammatory NF-κB/p65 Nuclear Translocation, ICAM-1 Expression and T-Cell Adhesiveness of Human Brain Microvascular Endothelial Cells
- (2015) Axel Haarmann et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dimethyl Fumarate Inhibits the Nuclear Factor κB Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein
- (2015) Irida Kastrati et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Melanocyte antigen triggers autoimmunity in human psoriasis
- (2015) Akiko Arakawa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine
- (2015) Armanda J. Onderdijk et al. JOURNAL OF IMMUNOLOGY
- DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
- (2015) Geoffrey O. Gillard et al. JOURNAL OF NEUROIMMUNOLOGY
- European S3-Guidelines on the systemic treatment of psoriasis vulgaris - Update 2015 - Short version - EDF in cooperation with EADV and IPC
- (2015) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Nrf2 and NF-κB Signaling Pathways Contribute to Porphyra-334-Mediated Inhibition of UVA-Induced Inflammation in Skin Fibroblasts
- (2015) Jina Ryu et al. Marine Drugs
- Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1αin Psoriasis
- (2015) Azael Torales-Cardeña et al. MEDIATORS OF INFLAMMATION
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- IL-4 abrogates TH17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells
- (2015) Emmanuella Guenova et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
- (2015) Erin E Longbrake et al. Multiple Sclerosis Journal
- Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro
- (2015) Melanie S. Brennan et al. PLoS One
- Immunology of Psoriasis
- (2014) Michelle A. Lowes et al. Annual Review of Immunology
- Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α)
- (2014) Guangzong Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dimethyl fumarate protection against collagen II degradation
- (2014) Ye Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Regulated genes in psoriatic skin during treatment with fumaric acid esters
- (2014) A.J. Onderdijk et al. BRITISH JOURNAL OF DERMATOLOGY
- Nuclear Heme Oxygenase-1 (HO-1) Modulates Subcellular Distribution and Activation of Nrf2, Impacting Metabolic and Anti-oxidant Defenses
- (2014) Chhanda Biswas et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE
- (2014) Hui Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
- (2014) G. L. Stritesky et al. JOURNAL OF IMMUNOLOGY
- Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
- (2014) J. Pene et al. JOURNAL OF IMMUNOLOGY
- Sulforaphane Protects from T Cell-Mediated Autoimmune Disease by Inhibition of IL-23 and IL-12 in Dendritic Cells
- (2014) J. Geisel et al. JOURNAL OF IMMUNOLOGY
- Nationwide population-based study of cause-specific death rates in patients with psoriasis
- (2014) E. Salahadeen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Herpes zoster as a risk factor for stroke and TIA: A retrospective cohort study in the UK
- (2014) J. Breuer et al. NEUROLOGY
- Immune sensing of nucleic acids in inflammatory skin diseases
- (2014) Olivier Demaria et al. Seminars in Immunopathology
- The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
- (2014) Roberto Lande et al. Nature Communications
- Detection of fumarate–glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism
- (2013) Stefan Dibbert et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Bimodal immune activation in psoriasis
- (2013) E. Christophers et al. BRITISH JOURNAL OF DERMATOLOGY
- GPR109A and Vascular Inflammation
- (2013) Joshua T. Chai et al. Current Atherosclerosis Reports
- Dimethyl fumarate: a Janus-faced substance?
- (2013) Frieder Kees EXPERT OPINION ON PHARMACOTHERAPY
- Dimethylfumarate Suppresses Adipogenic Differentiation in 3T3-L1 Preadipocytes through Inhibition of STAT3 Activity
- (2013) Hyeon-Ji Kang et al. PLoS One
- Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway
- (2012) Houman Ashrafian et al. Cell Metabolism
- Guidance on the diagnosis and clinical management of psoriasis
- (2012) S. N. Cohen et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten-Workshops
- (2012) Ulrich Mrowietz et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update
- (2012) Alexander Nast et al. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
- Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling
- (2012) Haiyan Peng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of dimethyl fumarate on neuroprotection and immunomodulation
- (2012) Philipp Albrecht et al. Journal of Neuroinflammation
- Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
- (2012) Lam C Tsoi et al. NATURE GENETICS
- Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
- (2012) Robert J. Fox et al. NEW ENGLAND JOURNAL OF MEDICINE
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
- (2012) Ralf Gold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin
- (2012) Julien Hanson et al. PHARMACOLOGY & THERAPEUTICS
- Mechanism of Chemical Activation of Nrf2
- (2012) Yun Li et al. PLoS One
- Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
- (2011) Ralf A. Linker et al. BRAIN
- Fumaric acid and its esters: An emerging treatment for multiple sclerosis with antioxidative mechanism of action
- (2011) R. Gold et al. CLINICAL IMMUNOLOGY
- Downregulation of endothelial adhesion molecules by dimethylfumarate, but not monomethylfumarate, and impairment of dynamic lymphocyte-endothelial cell interactions
- (2011) Katrin Wallbrecht et al. EXPERIMENTAL DERMATOLOGY
- Cytokine Secretion Pattern in Treatment of Lymphocytes of Multiple Sclerosis Patients with Fumaric Acid Esters
- (2011) Samaneh Zoghi et al. IMMUNOLOGICAL INVESTIGATIONS
- Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression
- (2011) B. Gesser et al. INFLAMMATION RESEARCH
- Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
- (2011) Kamran Ghoreschi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?
- (2011) Melissa García-Caballero et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Suppression of VEGFR2 Expression in Human Endothelial Cells by Dimethylfumarate Treatment: Evidence for Anti-Angiogenic Action
- (2011) Markus Meissner et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Fumarate Esters as Angiogenesis Inhibitors: Key to Action in Psoriasis?
- (2011) Jack L. Arbiser JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
- (2011) Slaheddine Marrakchi et al. NEW ENGLAND JOURNAL OF MEDICINE
- GATA3 Expression Is Decreased in Psoriasis and during Epidermal Regeneration; Induction by Narrow-Band UVB and IL-4
- (2011) Emőke Rácz et al. PLoS One
- Dimethylfumarate for Psoriasis
- (2010) H. Jorn Bovenschen et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Targeting glutathione by dimethylfumarate protects against experimental malaria by enhancing erythrocyte cell membrane scrambling
- (2010) Mehrdad Ghashghaeinia et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients
- (2010) Martin Rostami-Yazdi et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Angiogenesis drives psoriasis pathogenesis
- (2010) Regina Heidenreich et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
- (2010) Julien Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1β, TNF-α and IL-6 in an in-vitro model of brain inflammation
- (2010) Henrik Wilms et al. Journal of Neuroinflammation
- Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
- (2010) Ulrike Hüffmeier et al. NATURE GENETICS
- Fumaric acid diesters deprive cultured primary astrocytes rapidly of glutathione
- (2010) Maike M. Schmidt et al. NEUROCHEMISTRY INTERNATIONAL
- Fumaric acid dialkyl esters deprive cultured rat oligodendroglial cells of glutathione and upregulate the expression of heme oxygenase 1
- (2010) Anette Thiessen et al. NEUROSCIENCE LETTERS
- Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis
- (2009) D. Moharregh-Khiabani et al. Current Neuropharmacology
- Angiogenesis: The new potential target for the therapy of psoriasis?
- (2009) R. Heidenreich et al. DRUG NEWS & PERSPECTIVES
- β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
- (2009) Robert W. Walters et al. JOURNAL OF CLINICAL INVESTIGATION
- Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
- (2009) Dipyaman Ganguly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells
- (2009) W. A. Goodman et al. JOURNAL OF IMMUNOLOGY
- Functional Expression of Heme Oxygenase-1 in Human Differentiated Epidermis and Its Regulation by Cytokines
- (2009) Ikuko Numata et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Guidelines of care for the management of psoriasis and psoriatic arthritis
- (2009) Alan Menter et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- Psoriasis
- (2009) Frank O. Nestle et al. NEW ENGLAND JOURNAL OF MEDICINE
- The psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
- (2008) Hua Tang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorder
- (2008) Sumio Takegawa et al. CANCER SCIENCE
- Fumaric acid esters
- (2008) Martin Rostami Yazdi et al. CLINICS IN DERMATOLOGY
- IL-4-mediated fine tuning of IL-12p70 production by human DC
- (2008) Emmanuella Guenova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Detection of Metabolites of Fumaric Acid Esters in Human Urine: Implications for Their Mode of Action
- (2008) Martin Rostami-Yazdi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Dimethylfumarate Reduces Leukocyte Rolling in Vivo through Modulation of Adhesion Molecule Expression
- (2007) Simone A. Rubant et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started